This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Surmodics (SRDX) Enters Deal to be Acquired by GTCR for $627M
by Zacks Equity Research
Surmodics (SRDX) enters a definitive agreement to be acquired by renowned private equity company GTCR at an estimated total equity valuation of $627 million.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change SRDXNegative Net Change
medical medical-devices
Charles River (CRL) Launches Viral Vector Tech Transfer Program
by Zacks Equity Research
Charles River's (CRL) new Fast Track and Modular frameworks facilitate product development continuity via accelerated process transfer to its viral vector Center of Excellence.
RMDNegative Net Change CRLNegative Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?
by Zacks Equity Research
Investors are optimistic about DaVita's (DVA) strength in kidney care.
BSXPositive Net Change ECLPositive Net Change DVANegative Net Change HQYPositive Net Change
medical medical-devices
Veeva Systems (VEEV) Q1 Earnings Beat Estimates, Margins Up
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performance by both segments.
BSXPositive Net Change ALGNPositive Net Change RMDNegative Net Change VEEVNegative Net Change
earnings medical medical-devices
QIAGEN (QGEN) Develops Test for Research and CDx Application
by Zacks Equity Research
QIAGEN's (QGEN) next-generation sequencing test aims to aid personalized medicine research in solid tumor types, including ovarian cancer, and improve decentralized testing capabilities.
RMDNegative Net Change MYGNPositive Net Change QGENPositive Net Change MEDPPositive Net Change
medical medical-devices
Here's Why You Should Retain Globus Medical (GMED) Stock Now
by Zacks Equity Research
Investors are optimistic about Globus Medical (GMED) led by strong musculoskeletal prospects and raised guidance.
RMDNegative Net Change GMEDPositive Net Change MEDPPositive Net Change EHCPositive Net Change
medical medical-devices
Is The Options Market Predicting A Spike In Integra LifeScience (IART) Stock?
by Zacks Equity Research
Investors need to pay close attention to Integra LifeScience (IART) stock based on the movements in the options market lately.
IARTPositive Net Change
medical medical-devices
Zimmer Biomet (ZBH) Unlocks Growth Plan for Future Success
by Zacks Equity Research
Zimmer Biomet (ZBH) outlines a path for compelling and long-term topline growth, improved operational profitability, and increased free cash flow generation.
RMDNegative Net Change ZBHPositive Net Change MEDPPositive Net Change EHCPositive Net Change
medical medical-devices
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio Now
by Zacks Equity Research
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change LNTHPositive Net Change
medical medical-devices
Stryker (SYK) to Launch Gamma4 Hip Fracture System in Europe
by Zacks Equity Research
Stryker (SYK) announces plan to launch its Gamma4 Hip Fracture Nailing System in Europe. It completes initial surgeries successfully.
BSXPositive Net Change ECLPositive Net Change SYKPositive Net Change ALGNPositive Net Change
medical medical-devices
Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
by Zacks Equity Research
Revvity's (RVTY) strong product portfolio raises optimism about the stock.
DVANegative Net Change ALGNPositive Net Change EHCPositive Net Change RVTYPositive Net Change
medical medical-devices
Reasons Why You Should Retain Avantor (AVTR) Stock for Now
by Zacks Equity Research
Avantor's (AVTR) strong product portfolio raises optimism about the stock.
BSXPositive Net Change ECLPositive Net Change DVANegative Net Change AVTRPositive Net Change
medical medical-devices
Strength in HSA Likely to Aid HealthEquity's (HQY) Q1 Earnings
by Zacks Equity Research
Continued strength in HSA, aided by transfers of HSA Assets from BenefitWallet, is likely to have boosted HealthEquity's (HQY) top line in the fiscal first quarter.
MUNegative Net Change ALGNPositive Net Change HQYPositive Net Change BBWIPositive Net Change
earnings medical medical-devices
Tandem Diabetes (TNDM) Connects Mobi Pump With Dexcom G7 Sensor
by Zacks Equity Research
Tandem Diabetes' (TNDM) Mobi insulin pump is now compatible with Dexcom G7 CGM.
DXCMPositive Net Change TNDMNegative Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
Should You Buy EnerSys (ENS) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ENSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Zacks.com featured highlights include Sensus Healthcare, Diebold Nixdorf, Adtalem Global Education, Dycom Industries and Superior Group
by Zacks Equity Research
Sensus Healthcare, Diebold Nixdorf, Adtalem Global Education, Dycom Industries and Superior Group are part of the Zacks Screen of the Week article.
DBDNegative Net Change DYNegative Net Change SGCPositive Net Change ATGENegative Net Change SRTSNegative Net Change
computers construction consumer-discretionary medical-devices
Reasons to Hold Charles River (CRL) in Your Portfolio Now
by Zacks Equity Research
Investors remain optimistic about Charles River (CRL), owing to its acquisitions, thriving DSA segment and financial stability.
RMDNegative Net Change CRLNegative Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
Implied Volatility Surging for Abbot Laboratories (ABT) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Abbot Laboratories (ABT) stock based on the movements in the options market lately.
ABTPositive Net Change
medical medical-devices
Stryker (SYK) Issues Safety Notice for Its Total Knee System
by Zacks Equity Research
Stryker (SYK) issues urgent field safety notice for the Mako Total Knee systems, the application software of which generated software error codes. The company also shares risk mitigation steps.
BSXPositive Net Change ECLPositive Net Change SYKPositive Net Change ALGNPositive Net Change
medical medical-devices
Reasons to Retain PacBio (PACB) Stock in Your Portfolio
by Zacks Equity Research
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change PACBNegative Net Change
medical medical-devices
Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant
by Zacks Equity Research
Inspira Technologies' (IINN) ART100 recent approval highlights the company's innovative advancements in medical technology.
RMDNegative Net Change MEDPPositive Net Change EHCPositive Net Change IINNNegative Net Change
medical medical-devices
Philips (PHG) Boosts Medical Imaging Footprint With New Move
by Zacks Equity Research
Philips (PHG) expands its international footprint with the wide availability of VeriSight Pro 3D to several Hong Kong hospitals, strengthening its Diagnosis & Treatment segment.
PHGNegative Net Change DVANegative Net Change ALCPositive Net Change EHCPositive Net Change
medical medical-devices
Brookfield Renewable Corporation (BEPC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BEPCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Strattec Security (STRT) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STRTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Canopy Growth (CGC) Ahead of Q4 Earnings?
by Moumi Mondal
Canopy Growth's (CGC) rightsized cannabis-focused business is a major foundation for growth.
INGNPositive Net Change HQYPositive Net Change CGCNegative Net Change HIMSNegative Net Change
cannabis medical medical-devices